T. Rowe Price Health Sciences Fund (PRHSX) Research
This fund typically allocates a minimum of 80% of its total net assets (including any borrowed capital utilized for investment purposes) to the common stock shares of businesses within the health sciences domain. This includes companies focused on the research, development, manufacturing, or distribution of offerings related to healthcare, medicine, or the broader life sciences. While the portfolio has the liberty to invest in companies of any market capitalization, most of its holdings are projected to be in large- and medium-sized corporations. The fund operates as a non-diversified investment vehicle.
Market snapshot
- Symbol
- PRHSX
- Price
- $82.27
- Day change
- -0.36%
- Market cap
- $11.1B
- 52-week range
- 74.5-95.7
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- T. Rowe Price International Stock (PRITX)
- State Street Equity 500 Index Fund (SSSYX)
- T. Rowe Price Mid-Cap Value Fund (TRMCX)
- T. Rowe Price Retirement 2020 Fund (TRRBX)
- USAA 500 Index Fund (USPRX)
- Vanguard Target Retirement 2065 Fund (VLXVX)
- Allspring Special Mid Cap Value Fund (WFMDX)
- Allspring Special Mid Cap Value Fund (WFPRX)
Open T. Rowe Price Health Sciences Fund (PRHSX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.